TERT and liver cancer: Recently, next-generation genome sequencing studies on liver cancer revealed the existence of approximately 30 driver genes for liver cancer: Telomerase reverse transcriptase (TERT) overexpression, p53 mutations, and beta-catenin mutations are recurrent in human liver cancer associated with both hepatitis B and C (6).